SFI
BSX icon

Susquehanna Fundamental Investments’s Boston Scientific BSX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,400
Closed -$2.97M – 757
2025
Q1 		$2.97M Hold
29,400
– – 0.04% 432
2024
Q4 		$2.63M Buy
+29,400
New +$2.59M 0.04% 456
2024
Q2 		$2.27M Buy
+29,518
New +$2.16M 0.05% 384
2023
Q4 		– Sell
-217,451
Closed -$11.5M – 108
2023
Q3 		$11.5M Sell
217,451
-161,468
-43% -$8.47M 0.75% 37
2023
Q2 		$20.5M Sell
378,919
-358,503
-49% -$18.7M 0.75% 29
2023
Q1 		$36.9M Sell
737,422
-142,232
-16% -$6.7M 0.86% 19
2022
Q4 		$40.7M Buy
879,654
+10,256
+1% +$444K 0.7% 19
2022
Q3 		$33.7M Buy
+869,398
New +$34.9M 0.57% 21
2022
Q1 		$15.6M Buy
351,800
+115,800
+49% +$5.02M 0.3% 61
2021
Q4 		$10M Buy
+236,000
New +$9.92M 0.26% 89

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna Fundamental Investments's BSX Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 29,400 shares — an estimated $2.97M sold.

Susquehanna Fundamental Investments first reported a position in BSX in Q4 2021 and held it in 10 quarters. The position peaked at $40.7M in Q4 2022. 1,688 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 29,400 Boston Scientific shares in Q2 2025, an estimated $2.97M.
  • Susquehanna Fundamental Investments first reported a position in Boston Scientific in Q4 2021 and held it in 10 quarters.
  • Susquehanna Fundamental Investments's Boston Scientific position peaked at $40.7M in Q4 2022.
  • 1,688 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.